We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Agilent Technologies Introduces Verified Dissolution Components for Pharmaceutical Market

News   May 15, 2013

 
Agilent Technologies Introduces Verified Dissolution Components for Pharmaceutical Market
 
 
 

RELATED ARTICLES

Potential Drug for Reversing Mucosal Barrier Damage by HIV Tested in Preclinical Models

News

Research in preclinical models suggests that recombinant molecule could act as a topical anti-HIV microbicide.

READ MORE

Topical Immunotherapy Lowers Risk of Skin Cancer

News

A combination of two topical creams already shown to clear precancerous skin lesions from sun-damaged skin also lowers the risk that patients will later develop squamous cell carcinoma of the skin.

READ MORE

Researchers Patent Method for Making Anti-leukemia Compounds

News

Chemistry researchers at Oregon State University have patented a method for making anti-leukemia compounds that until now have only been available via an Asian tree that produces them.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE